Conference
HGS-ETR1, a fully human monoclonal antibody to the tumor necrosis factor-related apoptosis-inducing ligand death receptor 1 (TRAIL-R1) in patients with advanced solid cancer: Results of a phase 1 trial.
Authors
Hotte SJ; Hirte HW; Chen EX; Le LH; Corey A; Maclean M; Iacobucci A; Fox NL; Oza AM
Volume
23
Pagination
pp. 204S-204S
Publisher
AMER SOC CLINICAL ONCOLOGY
Publication Date
June 1, 2005
Name of conference
41st Annual Meeting of the American-Society-of-Clinical-Oncology
Conference place
Orlando, FL
Conference start date
May 13, 2005
Conference end date
May 17, 2005
Conference proceedings
JOURNAL OF CLINICAL ONCOLOGY
Issue
16
ISSN
0732-183X